Making a case for the artificial disk

By Peter Pollack

Is it an expensive fusion or a viable alternative?

As a principal investigator for the U.S. Food and Drug Administration’s clinical trials on using spinal artificial disks in the treatment of degenerative disk disease, Fabien D. Bitan, MD, is well-qualified to discuss the issues surrounding disk replacement as an alternative to spinal fusion.

This content is only available to members of the AAOS.

Please log in using the link at the top right corner of this page to access your exclusive AAOS member content.

Not a member? Become a member!